Recombinant CA19-9 Antibody [CA19.9/1390R]
Code | Size | Price |
---|
PSI-34-073-100ug | 100ug | £765.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG, k
Antibody Clonality: Recombinant Antibody
Antibody Clone: CA19.9/1390R
Regulatory Status: RUO
Target Species: Human
Applications:
- Immunofluorescence (IF)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Shipping:
blue ice
Storage:
Aliquot and Store at -20C. Avoid freez-thaw cycles.
Images
Documents
Further Information
Application Note:
Flow Cytometry: 2-4 ug/million cells in 0.1ml
Immunofluorescence: 5-10 ug/ml
Immunohistochemistry (FFPE): 5-10 ug/ml for 30 min at RT
Prediluted IHC only format: incubate for 30 min at RT (1)
Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.
Immunofluorescence: 5-10 ug/ml
Immunohistochemistry (FFPE): 5-10 ug/ml for 30 min at RT
Prediluted IHC only format: incubate for 30 min at RT (1)
Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Background:
CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.
Buffer:
PBS with 0.1 mg/ml BSA and 0.05% sodium azide
Concentration:
0.2 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Purified human protein used as the immunogen for the recombinant CA19-9 antibody.
Physical State:
Liquid
Purification:
Protein A affinity
Research Area:
Cancer
Swissprot #:
Not Known
User NOte:
Optimal dilutions for each application to be determined by the researcher